Back to marketplace

3.7 Tumor Testing and Transplantation

No description yet. This curated deck is ready for daily study.

Total cards: 13•Content version: v4•Public deck•Updated: 8/1/2026

Card preview (13)

#1
Front (Question)

A patient had surgery for colorectal cancer, after which he received chemotherapy for 6 months. The test for carcinoembryonic antigen (CEA) was normal at this time. One year later, the bimonthly level of CEA was elevated (above 10 ng/mL). An examination and biopsy revealed recurrence of a small tumor. What was the value of the results provided by the CEA test in this clinical situation? A. Diagnostic information B. Information for further treatment C. Information on the immunologic response of the patient D. No useful clinical information in this case

Back (Answer)

B. Information for further treatment

#2
Front (Question)

A carbohydrate antigen 125 assay (CA-125) was performed on a woman with ovarian cancer. After treatment, the levels fell significantly. An examination performed later revealed recurrence of the tumor, but the CA-125 levels remained low. How can this finding be explained? A. Test error B. CA-125 was the wrong laboratory test; α-fetoprotein (AFP) is a better test to monitor ovarian cancer C. CA-125 may not be sensitive enough when used alone to monitor tumor development D. CA-125 is not specific enough to detect only one type of tumor

Back (Answer)

C. CA-125 may not be sensitive enough when used alone to monitor tumor development

#3
Front (Question)

What is the correct procedure upon receipt of a test request for human chorionic gonadotropin (hCG) on the serum of a 60-year-old man? A. Return the request; hCG is not performed on men B. Perform a qualitative hCG test to see if hCG is present C. Perform the test; hCG may be increased in testicular tumors D. Perform the test but use different standards and controls

Back (Answer)

C. Perform the test; hCG may be increased in testicular tumors

#4
Front (Question)

Would an hCG test using a monoclonal antibody against the β-subunit of hCG likely be affected by an increased level of follicle-stimulating hormone (FSH)? A. Yes, the β-subunit of FSH is identical to that of hCG B. No, the test would be specific for the β-subunit of hCG C. Yes, a cross reaction would occur because of structural similarities D. No, the structure of FSH and hCG are not at all similar

Back (Answer)

B. No, the test would be specific for the β-subunit of hCG

#5
Front (Question)

Which of the following substances, sometimes used as a tumor marker, is increased two or threefold in a normal pregnancy? A. Alkaline phosphatase (ALP) B. Calcitonin C. Adrenocortocotropic hormone (ACTH) D. Neuron-specific enolase

Back (Answer)

A. Alkaline phosphatase (ALP)

#6
Front (Question)

What is an advantage of performing a prostate-specific antigen (PSA) test for prostate cancer? A. PSA is stable in serum and not affected by digital rectal examination B. PSA is increased only in prostatic malignancy C. A normal serum level rules out malignant prostatic disease D. The percentage of free PSA is elevated in persons with malignant disease

Back (Answer)

A. PSA is stable in serum and not affected by digital rectal examination

#7
Front (Question)

Which method is the most sensitive for quantitation of AFP? A. Double immunodiffusion B. Electrophoresis C. Enzyme immunoassay D. Particle agglutination

Back (Answer)

C. Enzyme immunoassay

#8
Front (Question)

How is HLA typing used in the investigation of genetic diseases? A. For prediction of the severity of the disease B. For genetic linkage studies C. For direct diagnosis of disease D. Is not useful in this situation

Back (Answer)

B. For genetic linkage studies

#9
Front (Question)

Select the best donor for a man, blood type AB, in need of kidney transplantation. A. His brother, type AB, HLA matched for class II antigens B. His mother, type B, HLA matched for class I antigens C. His cousin, type O, HLA matched for major class II antigens D. Deceased donor, type O, HLA matched for some class I and II antigens

Back (Answer)

A. His brother, type AB, HLA matched for class II antigens

#10
Front (Question)

Interpret the following microcytotoxicity target cell results: A9 and B12 cells = damaged A1 and Aw19 cells = intact A. Positive for A1 and Aw19; negative for A9 and B12 B. Negative for A1 and Aw19; positive for A9 and B12 C. Error in test system; retest D. Impossible to determine

Back (Answer)

B. Negative for A1 and Aw19; positive for A9 and B12

#11
Front (Question)

Which method, classically used for HLA-D typing, is often used to determine the compatibility between a living organ donor and a recipient? A. Flow cytometry B. Mixed lymphocyte culture (MLC) C. Primed lymphocyte test D. Restriction fragment length polymorphism (RFLP)

Back (Answer)

B. Mixed lymphocyte culture (MLC)

#12
Front (Question)

SITUATION: Cells type negative for all HLA antigens in a complement-dependent cytotoxicity assay. What is the most likely cause? A. Too much supravital dye was added B. Rabbit complement is inactivated C. All leukocytes are dead D. Antisera is too concentrated

Back (Answer)

B. Rabbit complement is inactivated

#13
Front (Question)

What method may be used for tissue typing instead of serological HLA typing? A. PCR B. Southern blotting C. RFLP D. All of these options

Back (Answer)

D. All of these options